Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-κB-dependent inflammatory/MMP-9 pathway

CNS Neurosci Ther. 2014 Feb;20(2):182-5. doi: 10.1111/cns.12194. Epub 2013 Nov 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Brain Injuries / drug therapy*
  • Brain Injuries / etiology*
  • Disease Models, Animal
  • Matrix Metalloproteinase 9 / metabolism*
  • NF-kappa B / metabolism*
  • Neoplasm Proteins / metabolism
  • Neurologic Examination
  • Nucleocytoplasmic Transport Proteins / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Resveratrol
  • Stilbenes / therapeutic use*
  • Subarachnoid Hemorrhage / complications*

Substances

  • Antioxidants
  • NF-kappa B
  • Neoplasm Proteins
  • Nucleocytoplasmic Transport Proteins
  • Stilbenes
  • p65 oncofetal mRNA transport protein, rat
  • Matrix Metalloproteinase 9
  • Resveratrol